Viking Therapeutics Inc’s filing revealed that its Chief Financial Officer ZANTE GREG unloaded Company’s shares for reported $10.09 million on Oct 28 ’24. In the deal valued at $76.61 per share,131,687 shares were sold. As a result of this transaction, ZANTE GREG now holds 149,366 shares worth roughly $11.13 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, GREG ZANTE bought 131,687 shares, generating $10,275,537 in total proceeds.
Before that, Rouan Sarah Kathryn sold 11,000 shares. Viking Therapeutics Inc shares valued at $889,790 were divested by the Director at a price of $80.89 per share. As a result of the transaction, Rouan Sarah Kathryn now holds 0 shares, worth roughly $0.0.
JP Morgan initiated its Viking Therapeutics Inc [VKTX] rating to an Overweight in a research note published on September 11, 2024; the price target was $80. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in late June with a ‘”an Overweight”‘ rating. Raymond James also remained covering VKTX and has increased its forecast on May 16, 2024 with a “Strong buy” recommendation from previously “an Outperform” rating. Oppenheimer maintained its rating on March 26, 2024. It rated VKTX as “an Outperform”.
Price Performance Review of VKTX
On Monday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -4.50% to $74.52. Over the last five days, the stock has gained 15.82%. Viking Therapeutics Inc shares have risen nearly 300.43% since the year began. Nevertheless, the stocks have risen 671.03% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $8.28 was recorded on 01/03/24. SMA at 50 days reached $63.88, while 200 days put it at $58.79.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 71.87, which if violated will result in even more drops to 69.22. On the upside, there is a resistance level at 79.45. A further resistance level may holdings at 84.38. The Relative Strength Index (RSI) on the 14-day chart is 62.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 8.76, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 33.19%. Stochastics %K at 78.96% indicates the stock is a holding.
How much short interest is there in Viking Therapeutics Inc?
A steep rise in short interest was recorded in Viking Therapeutics Inc stocks on 2024-10-15, dropping by -1.51 million shares to a total of 14.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 15.91 million shares. There was a decline of -10.51%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 07, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $110 price target.
